ClearBridge Investments’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,045,918
| Closed | -$8.69M | – | 737 |
|
|
2024
Q3 | $8.69M | Sell |
1,045,918
-8,191
| -0.8% | -$68.1K | 0.01% | 544 |
|
|
2024
Q2 | $7.55M | Buy |
1,054,109
+253,887
| +32% | +$1.82M | 0.01% | 562 |
|
|
2024
Q1 | $6.94M | Buy |
800,222
+21,200
| +3% | +$184K | 0.01% | 568 |
|
|
2023
Q4 | $5.1M | Sell |
779,022
-2,300,571
| -75% | -$15.1M | ﹤0.01% | 579 |
|
|
2023
Q3 | $30.8M | Sell |
3,079,593
-28,370
| -0.9% | -$284K | 0.03% | 376 |
|
|
2023
Q2 | $38.6M | Sell |
3,107,963
-132,200
| -4% | -$1.64M | 0.03% | 354 |
|
|
2023
Q1 | $45.4M | Buy |
3,240,163
+42,052
| +1% | +$589K | 0.04% | 332 |
|
|
2022
Q4 | $45.8M | Buy |
3,198,111
+222,376
| +7% | +$3.18M | 0.05% | 329 |
|
|
2022
Q3 | $76M | Buy |
2,975,735
+267,860
| +10% | +$6.84M | 0.08% | 239 |
|
|
2022
Q2 | $76.9M | Buy |
2,707,875
+277,260
| +11% | +$7.88M | 0.07% | 251 |
|
|
2022
Q1 | $85.7M | Sell |
2,430,615
-235,082
| -9% | -$8.29M | 0.06% | 272 |
|
|
2021
Q4 | $112M | Buy |
2,665,697
+11,171
| +0.4% | +$468K | 0.08% | 230 |
|
|
2021
Q3 | $130M | Buy |
2,654,526
+55,397
| +2% | +$2.72M | 0.09% | 202 |
|
|
2021
Q2 | $108M | Buy |
2,599,129
+1,045,382
| +67% | +$43.6M | 0.08% | 227 |
|
|
2021
Q1 | $55.4M | Buy |
1,553,747
+348,492
| +29% | +$12.4M | 0.04% | 336 |
|
|
2020
Q4 | $33.8M | Buy |
+1,205,255
| New | +$33.8M | 0.03% | 390 |
|